Rpo LLC Buys New Shares in AC Immune SA (NASDAQ:ACIU)

Rpo LLC purchased a new position in shares of AC Immune SA (NASDAQ:ACIU) during the 4th quarter, HoldingsChannel reports. The firm purchased 18,728 shares of the company’s stock, valued at approximately $51,000.

Separately, Geode Capital Management LLC raised its holdings in shares of AC Immune by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 58,296 shares of the company’s stock valued at $220,000 after purchasing an additional 3,499 shares in the last quarter. 51.36% of the stock is owned by hedge funds and other institutional investors.

AC Immune Stock Performance

Shares of NASDAQ ACIU opened at $1.88 on Thursday. The stock’s 50-day simple moving average is $2.43 and its 200-day simple moving average is $2.88. The firm has a market capitalization of $188.77 million, a PE ratio of -4.09 and a beta of 1.49. AC Immune SA has a fifty-two week low of $1.77 and a fifty-two week high of $4.98.

Analyst Ratings Changes

Separately, HC Wainwright reiterated a “buy” rating and set a $16.00 target price on shares of AC Immune in a research note on Friday, March 14th.

About AC Immune

AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases.